Biofrontera Inc. (BFRI)
USD 0.8
(-4.78%)
USD 0.8
(-4.78%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 23.13 Million USD | -14.32% |
| 2022 | 27 Million USD | -35.52% |
| 2021 | 41.88 Million USD | 128.73% |
| 2020 | 18.31 Million USD | -68.93% |
| 2019 | 58.93 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 10.66 Million USD | -64.45% |
| 2024 Q1 | 29.99 Million USD | 29.61% |
| 2023 Q4 | 23.13 Million USD | -30.02% |
| 2023 FY | 23.13 Million USD | -14.32% |
| 2023 Q3 | 33.06 Million USD | 11.21% |
| 2023 Q2 | 29.73 Million USD | 17.92% |
| 2023 Q1 | 25.21 Million USD | -6.63% |
| 2022 Q2 | 36.39 Million USD | 14.49% |
| 2022 Q1 | 31.78 Million USD | -24.1% |
| 2022 FY | 27 Million USD | -35.52% |
| 2022 Q4 | 27 Million USD | -16.82% |
| 2022 Q3 | 32.46 Million USD | -10.8% |
| 2021 Q2 | 19.06 Million USD | 3.03% |
| 2021 Q4 | 41.88 Million USD | 27.94% |
| 2021 Q3 | 32.73 Million USD | 71.72% |
| 2021 FY | 41.88 Million USD | 128.73% |
| 2021 Q1 | 18.5 Million USD | 1.05% |
| 2020 FY | 18.31 Million USD | -68.93% |
| 2020 Q4 | 18.31 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 58.93 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aquestive Therapeutics, Inc. | 163.9 Million USD | 85.883% |
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | 97.559% |
| Journey Medical Corporation | 56.49 Million USD | 59.045% |
| Dynavax Technologies Corporation | 375.02 Million USD | 93.83% |
| Esperion Therapeutics, Inc. | 660.79 Million USD | 96.498% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | 83.094% |
| Pacira BioSciences, Inc. | 704.25 Million USD | 96.714% |
| PainReform Ltd. | 2.69 Million USD | -759.866% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | -8.553% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -276.881% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -276.881% |
| SCYNEXIS, Inc. | 55.45 Million USD | 58.271% |
| Silver Spike Investment Corp. | 3 Million USD | -668.781% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | -151.604% |
| Alpha Teknova, Inc. | 38.55 Million USD | 39.978% |
| Alvotech | 1.88 Billion USD | 98.771% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | 95.094% |
| Bright Green Corporation | 6.43 Million USD | -259.407% |
| Embecta Corp. | 2.03 Billion USD | 98.864% |
| Safety Shot Inc | 3.89 Million USD | -494.521% |
| Procaps Group, S.A. | 462.06 Million USD | 94.992% |
| Cosmos Health Inc. | 30.25 Million USD | 23.514% |
| Theratechnologies Inc. | 98.63 Million USD | 76.542% |
| Harrow Health, Inc. | 241.75 Million USD | 90.429% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | -164.265% |
| DURECT Corporation | 30.4 Million USD | 23.9% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | 95.253% |
| Cronos Group Inc. | 43.73 Million USD | 47.094% |
| OptiNose, Inc. | 194.33 Million USD | 88.093% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | 97.169% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | 52.237% |
| RedHill Biopharma Ltd. | 20.97 Million USD | -10.301% |
| Organogenesis Holdings Inc. | 181.36 Million USD | 87.242% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | -513.419% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | 55.939% |
| Radius Health, Inc. | 804.29 Million USD | 97.123% |
| Universe Pharmaceuticals INC | 13.75 Million USD | -68.231% |
| ProPhase Labs, Inc. | 42.54 Million USD | 45.612% |
| Phibro Animal Health Corporation | 725.54 Million USD | 96.811% |
| Procaps Group S.A. | 462.06 Million USD | 94.992% |
| TherapeuticsMD, Inc. | 14.02 Million USD | -65.019% |
| Viatris Inc. | 27.21 Billion USD | 99.915% |
| Rockwell Medical, Inc. | 30.88 Million USD | 25.073% |
| Aytu BioPharma, Inc. | 90.37 Million USD | 74.398% |
| SIGA Technologies, Inc. | 57.97 Million USD | 60.09% |
| Tilray Brands, Inc. | 892.11 Million USD | 97.406% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | 89.473% |
| Shineco, Inc. | 47.6 Million USD | 51.39% |
| PetIQ, Inc. | 645.22 Million USD | 96.414% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -10441.109% |
| Incannex Healthcare Limited | 5.83 Million USD | -296.895% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | 97.73% |
| Alimera Sciences, Inc. | 107.35 Million USD | 78.446% |
| Assertio Holdings, Inc. | 148.41 Million USD | 84.409% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.89 Million USD | -1120.434% |
| Clever Leaves Holdings Inc. | 7.02 Million USD | -229.334% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -172.527% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | 86.655% |
| Hempacco Co., Inc. | 18.82 Million USD | -22.933% |
| Talphera, Inc. | 6.29 Million USD | -267.87% |
| Alvotech | 1.88 Billion USD | 98.771% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | 86.594% |
| Lantheus Holdings, Inc. | 835.25 Million USD | 97.23% |
| Currenc Group, Inc. | 177.67 Million USD | 86.977% |
| Kamada Ltd. | 109.96 Million USD | 78.958% |
| Indivior PLC | 1.95 Billion USD | 98.814% |
| Evoke Pharma, Inc. | 9.64 Million USD | -139.83% |
| Flora Growth Corp. | 17.22 Million USD | -34.357% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -172.527% |
| Evolus, Inc. | 209.68 Million USD | 88.965% |
| HUTCHMED (China) Limited | 536.38 Million USD | 95.686% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | 97.351% |
| Akanda Corp. | 12.66 Million USD | -82.644% |